Dursun Dursunoglu

Dursun Dursunoglu

Auto-generated profile, based on publicly available information

Dursun Dursunoglu

PAMUKKALE UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CARDIOLOGY

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Future Cardiology
Verified
Journal Article
Closed access
SYSamet Yilmaz
Samet Yilmaz
MKMehmet Kilinc
Mehmet Kilinc
MAMehmet Koray Adali
Mehmet Koray Adali
IBIpek Buber
Ipek Buber
DDDursun Dursunoglu
Dursun Dursunoglu
Aim: In this study, our aim was to determine clinical factors related to the recovery of the conduction system in patients presenting with atrioventricular (AV) block. Materials & methods: A total of 178 patients who were hospitalized at a tertiary center due to second- or third-degree AV block were retrospectively analyzed. Results: During hospital follow-up, 19.1% of patients had fully recovered from AV block. According to a logistic regression analysis; younger age (odds ratio [OR]: 0.950; 95% CI: 0.932-0.967; p < 0.001), presenting with acute coronary syndrome (OR: 18.863; 95% CI: 3.776-94.222; p < 0.001), β-blocker usage (OR: 12.081; 95% CI: 3.498-41.726; p < 0.001), high serum creatinine levels (OR: 4.338; 95% CI: 2.110-8.918; p < 0.001) and no calcification at the aortic valve (OR: 0.189; 95% CI: 0.050-0.679; p = 0.011) were found to be related to resolution of AV block. Conclusion: It is crucial to know the reversible causes of AV block to prevent unnecessary permanent pacemaker implantation.

26 September 2025 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
SKSeçim Kolak
Seçim Kolak
NDNeşe Dursunoğlu
Neşe Dursunoğlu
DDDursun Dursunoğlu
Dursun Dursunoğlu
OÇOzan Çetin
Ozan Çetin
This study aimed to determine the incidence of chronic thromboembolic pulmonary hypertension (CTEPH) following acute pulmonary embolism (PE) and to identify associated risk factors. A total of 256 adult patients diagnosed with acute PE in 2018 and 2019 at a tertiary care center were retrospectively evaluated. Diagnostic and follow-up procedures included clinical scoring, echocardiography, computed tomography pulmonary angiography (CTPA), and/or ventilation/perfusion (V/Q) scintigraphy. To assess the development of CTEPH, we analyzed baseline characteristics and follow-up data for each cohort over a two-year period: 2018 to 2020 for patients diagnosed in 2018, and 2019 to 2021 for those diagnosed in 2019. Right heart catheterization (RHC) findings and follow-up imaging at the third and sixth months were reviewed. Demographic, clinical, laboratory, and radiological variables were compared between patients with and without CTEPH. The incidence of CTEPH was 7.8% (n=20). Right ventricular (RV) dilatation at initial imaging was significantly more frequent in the CTEPH group (p=0.042). At both the third and sixth months, elevated systolic pulmonary artery pressure (sPAP) >50 mmHg, tricuspid regurgitation (TR), and tricuspid regurgitation velocity (TRV) >2.8 m/s were significantly more common in CTEPH patients (p<0.05). No significant association was found with genetic thrombophilia, whereas antiphospholipid antibodies and lupus anticoagulant were more prevalent but not statistically significant. Although rare, CTEPH is associated with high morbidity and mortality but remains potentially curable if diagnosed early. Early signs such as RV dysfunction may help identify high-risk patients. Therefore, structured follow-up protocols are essential to ensure timely diagnosis and referral to specialized centers.